Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zhen Gong, Li Xia, Rune Xu, Min Luo, Hongxiang Deng, Zhiping Kang, Leping Liu, Yaqing Liu, Fangjie Zhang & Jian Shi. (2021) The Clinical Effects of Febuxostat Alone or Combined with Arthroscopic Surgery for Gout: A Single-Center Retrospective Study. Journal of Inflammation Research 14, pages 4509-4517.
Read now
Read now
Atalay Dogru, Ayse Balkarli, Cemile Canan Karatay, Veli Cobankara & Mehmet Sahin. (2019) Bone mineral density and serum osteocalcin levels in patients with gout. Acta Clinica Belgica 74:4, pages 252-257.
Read now
Read now
Articles from other publishers (36)
Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi, Robert Terkeltaub, Nicola Dalbeth, Wesley DeHaan, Rehan Azeem, Peter G Traber & Robert T Keenan. (2024) The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout. Rheumatology 63:4, pages 1058-1067.
Crossref
Crossref
Naomi Schlesinger, Fernando Pérez-Ruiz & Frédéric Lioté. (2023) Mechanisms and rationale for uricase use in patients with gout. Nature Reviews Rheumatology 19:10, pages 640-649.
Crossref
Crossref
Daniel Selvadurai, Matthew J Coleshill, Richard O Day, Nancy E Briggs, Marcel Schulz, Jennifer Reath & Eindra Aung. (2023) Patient factors and health outcomes associated with illness perceptions in people with gout. Rheumatology.
Crossref
Crossref
Okelue E Okobi, Helen Oletu, Adaeze B Chukwuedozie-Echeazu, Valentine C Keke, Onyinyechukwu B Nwachukwu, Henrietta S Akunne, Chinwendum U Ekpemiro, Uchechukwu S Oranika, Ngozi T Akueme, Oyewole E Akanle, Buchi C Ogbuagu & Linda A Mbah. (2023) The Stiff Joint: Comparative Evaluation of Monotherapy and Combination Therapy With Urate Lowering Agents in Managing Acute Gout. Cureus.
Crossref
Crossref
Xiaona Gan, Bo Peng, Liang Chen, Yanjun Jiang, Tingzhao Li, Bo Li & Xiaodong Liu. (2023) Identification of Xanthine Oxidase Inhibitors from Celery Seeds Using Affinity Ultrafiltration–Liquid Chromatography–Mass Spectrometry. Molecules 28:16, pages 6048.
Crossref
Crossref
Anna Kochanowska, Przemysław Rusztyn, Karolina Szczerkowska, Stanisław Surma, Aleksandra Gąsecka, Miłosz J. Jaguszewski, Łukasz Szarpak & Krzysztof J. Filipiak. (2023) Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action. Journal of Cardiovascular Development and Disease 10:7, pages 268.
Crossref
Crossref
Hongfu Jin, Miao He, Guang Yang, Wenqing Xie, Dengjie Yu, Hengzhen Li, Wenfeng Xiao & Yusheng Li. (2022) A Retrospective Study of the Perioperative Period Management of Joint Arthroplasty in Patients with Chronic Kidney Disease. Orthopaedic Surgery 15:2, pages 591-605.
Crossref
Crossref
Jingyang Zhang, Mengmeng Chen, Yuan Peng, Shuang Li, Dianpeng Han, Shuyue Ren, Kang Qin, Sen Li, Tie Han, Yu Wang & Zhixian Gao. (2022) Wearable biosensors for human fatigue diagnosis: A review. Bioengineering & Translational Medicine 8:1.
Crossref
Crossref
M. R. Gnid, T. I. Pupin, O. M. Vynogradova, R. M. Gnid, L. Yu. Minko & M. T. Sloboda. (2022) Study of Markers of Purine and Protein Metabolism in Blood Serum in Patients with Generalized Periodontitis Associated with Gout. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 7:5, pages 165-168.
Crossref
Crossref
I. E. Chazova, Yu. V. Zhernakova, O. A. Kislyak, V. I. Podzolkov, E. V. Oshchepkova, O. Yu. Mironova & N. V. Blinova. (2022) Consensus on patients with hyperuricemia and high cardiovascular risk treatment: 2022. Systemic Hypertension 19:1, pages 5-22.
Crossref
Crossref
Valérie Tikhonoff, Edoardo Casiglia, Paolo Spinella, Carlo M. Barbagallo, Michele Bombelli, Arrigo F. G. Cicero, Massimo Cirillo, Pietro Cirillo, Giovambattista Desideri, Lanfranco D’elia, Claudio Ferri, Ferruccio Galletti, Loreto Gesualdo, Cristina Giannattasio, Guido Iaccarino, Francesca Mallamaci, Alessandro Maloberti, Stefano Masi, Alberto Mazza, Maria Lorenza Muiesan, Pietro Nazzaro, Paolo Palatini, Gianfranco Parati, Roberto Pontremoli, Fosca Quarti-Trevano, Marcello Rattazzi, Giulia Rivasi, Massimo Salvetti, Giuliano Tocci, Andrea Ungar, Paolo Verdecchia, Francesca Viazzi, Agostino Virdis, Massimo Volpe, Guido Grassi & Claudio Borghi. (2021) Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study. Journal of Human Hypertension 36:11, pages 976-982.
Crossref
Crossref
Serena Del Turco, Luca Bastiani, Fabrizio Minichilli, Patrizia Landi, Giuseppina Basta, Alessandro Pingitore & Cristina Vassalle. (2022) Interaction of Uric Acid and Neutrophil-to-Lymphocyte Ratio for Cardiometabolic Risk Stratification and Prognosis in Coronary Artery Disease Patients. Antioxidants 11:11, pages 2163.
Crossref
Crossref
Gaetano Alfano, Rossella Perrone, Francesco Fontana, Giulia Ligabue, Silvia Giovanella, Annachiara Ferrari, Mariacristina Gregorini, Gianni Cappelli, Riccardo Magistroni & Gabriele Donati. (2022) Rethinking Chronic Kidney Disease in the Aging Population. Life 12:11, pages 1724.
Crossref
Crossref
Bowen Chang, Xuanzhi Wang, Peng Chen, Chen Ni, Chaoshi Niu & Haochen Guan. (2022) Low serum uric acid levels are associated with incidence and severity in trigeminal neuralgia. Neurological Sciences 43:10, pages 6053-6058.
Crossref
Crossref
Mousa Abujbara, Huda M Al Hourani, Reem Ibrahim Al-Raoush, Yousef S Khader & Kamel Ajlouni. (2022) Prevalence of Hyperuricemia and Associated Factors Among Type 2 Diabetic Patients in Jordan. International Journal of General Medicine Volume 15, pages 6611-6619.
Crossref
Crossref
Xiaofei Liu, Baige Li, Xiaohuan Zhang, Shiyan Mo, Dongfeng Liang & Jian Zhu. (2021) Factors associated with bone erosion in patients with gout: A dual-energy gemstone spectral imaging computed tomography study. Modern Rheumatology.
Crossref
Crossref
Yanqun WuShunhua WangXiaoqing Xu. (2021) Correlation of Serum Cystatin C with Renal Function in Gout Patients with Renal Injury. Journal of Interferon & Cytokine Research 41:9, pages 329-335.
Crossref
Crossref
Jaskamal Padda, Khizer Khalid, Abdulelah H Almanie, Hussam Al Hennawi, Krutagni Adwait Mehta, Ransirini Wijeratne Fernando, Sandeep Padda, Ayden Charlene Cooper & Gutteridge Jean-Charles. (2021) Hyperuricemia in Patients With Coronary Artery Disease and Its Association With Disease Severity. Cureus.
Crossref
Crossref
Rajesh Basnet, Sandhya Khadka, Buddha Bahadur Basnet, Til Bahadur Basnet, Buddhi Bal Chidi, Sanjeev Nirala, Radheshyam Gupta & Bidur Sharma. (2021) Xanthine Oxidase and Transforming Growth Factor Beta-activated Kinase 1: Potential Targets for Gout Intervention. Current Rheumatology Reviews 17:2, pages 153-161.
Crossref
Crossref
Yoon-Jeong Oh & Ki Won Moon. (2021) Presence of tophi is associated with a rapid decline in the renal function in patients with gout. Scientific Reports 11:1.
Crossref
Crossref
Megan Francis-Sedlak, Brian LaMoreaux, Lissa Padnick-Silver, Robert J. Holt & Alfonso E. Bello. (2020) Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study. Rheumatology and Therapy 8:1, pages 183-197.
Crossref
Crossref
Ilkay E. Orhan & Fatma S.S. Deniz. (2021) Natural Products and Extracts as Xantine Oxidase Inhibitors - A Hope for Gout Disease?. Current Pharmaceutical Design 27:2, pages 143-158.
Crossref
Crossref
Chen Sun, Mingyu Zhang, Yanhong Zhao, Jianxin Pang, Ying Peng & Jiang Zheng. (2020) An LC-MS/MS- and hURAT1 cell-based approach for screening of uricosuric agents. Journal of Chromatography B 1159, pages 122336.
Crossref
Crossref
Naomi Schlesinger & Peter E. Lipsky. (2020) Pegloticase treatment of chronic refractory gout: Update on efficacy and safety. Seminars in Arthritis and Rheumatism 50:3, pages S31-S38.
Crossref
Crossref
Edoardo Casiglia, Valérie Tikhonoff, Agostino Virdis, Stefano Masi, Carlo M. Barbagallo, Michele Bombelli, Bernardino Bruno, Arrigo F.G. Cicero, Massimo Cirillo, Pietro Cirillo, Giovambattista Desideri, Lanfranco D’Elia, Claudio Ferri, Ferruccio Galletti, Loreto Gesualdo, Cristina Giannattasio, Guido Iaccarino, Luciano Lippa, Francesca Mallamaci, Alessandro Maloberti, Alberto Mazza, Maria Lorenza Muiesan, Pietro Nazzaro, Paolo Palatini, Gianfranco Parati, Roberto Pontremoli, Fosca Quarti-Trevano, Marcello Rattazzi, Giulia Rivasi, Massimo Salvetti, Giuliano Tocci, Andrea Ungar, Paolo Verdecchia, Francesca Viazzi, Massimo Volpe, Guido Grassi & Claudio Borghi. (2020) Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study. Journal of Hypertension 38:3, pages 412-419.
Crossref
Crossref
Shi Tai, Xuping Li, Zhaowei Zhu, Liang Tang, Hui Yang, Liyao Fu, Xinqun Hu, Zhenfei Fang & Shenghua Zhou. (2020) Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome. Cardiovascular Therapeutics 2020, pages 1-10.
Crossref
Crossref
Juan Yang, Guangxi Li, Donglin Xiong, Tony Y. Chon & Brent A. Bauer. (2020) The Impact of Natural Product Dietary Supplements on Patients with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-10.
Crossref
Crossref
Trivadila, I. Oktaviani & D. Iswantini. Inhibition of tempuyung (Sonchus arvensis) water extract fractions against xanthine oxidase by electrochemical method. Inhibition of tempuyung (Sonchus arvensis) water extract fractions against xanthine oxidase by electrochemical method.
Irina E Chazova, Juliya V Zhernakova, Oksana A Kisliak, Sergey V Nedogoda, Valery I Podzolkov, Elena V Oshchepkova, Irina V Medvedeva, Olga Iu Mironova & Nataliia V Blinova. (2019) Consensus on patients with hyperuricemia and high cardiovascular risk treatment. Systemic Hypertension 16:4, pages 8-21.
Crossref
Crossref
Gurkirpal Singh, Bharathi Lingala & Alka Mithal. (2019) Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology 58:12, pages 2177-2180.
Crossref
Crossref
Fengchun Zhang, Zhichun Liu, Lindi Jiang, Hao Zhang, Dongbao Zhao, Yang Li, Hejian Zou, Xiaoyue Wang, Xiangpei Li, Bingyin Shi, Jianhua Xu, Hongjie Yang, Shaoxian Hu & Shen Qu. (2019) A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout. Rheumatology and Therapy 6:4, pages 543-557.
Crossref
Crossref
N Lawrence Edwards, Jasvinder A Singh, Orrin Troum, Anthony E Yeo & Peter E Lipsky. (2019) Characterization of patients with chronic refractory gout who do and do not have clinically apparent tophi and their response to pegloticase. Rheumatology 58:8, pages 1422-1431.
Crossref
Crossref
Brian F. Mandell, Anthony E. Yeo & Peter E. Lipsky. (2018) Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Hui Wang, Ying Peng, Tingjian Zhang, Qunsheng Lan, Huimin Zhao, Wenbao Wang, Yufei Zhao, Xu Wang, Jianxin Pang, Shaojie Wang & Jiang Zheng. (2017) Metabolic Epoxidation Is a Critical Step for the Development of Benzbromarone-Induced Hepatotoxicity. Drug Metabolism and Disposition 45:12, pages 1354-1363.
Crossref
Crossref
Yong Yang, Xiaoying Chen, Haochang Hu, Yuting Jiang, Hang Yu, Jie Dai, Yiyi Mao & Shiwei Duan. (2017) Elevated UMOD methylation level in peripheral blood is associated with gout risk. Scientific Reports 7:1.
Crossref
Crossref
Rulan Yin, Haixia Cao, Ting Fu, Qiuxiang Zhang, Lijuan Zhang, Liren Li & Zhifeng Gu. (2017) The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study. Rheumatology International 37:7, pages 1187-1194.
Crossref
Crossref